Congenital heart disease (CHD) remains the commonest cause of death from structural birth defect. It is generally accepted that 8 per 1,000 live births result in CHD [1] . However, reported prevalence of CHD varies widely among large epidemiological studies [2] [3] [4] [5] [6] [7] [8] . The precise prevalence data are obviously important as a measure of the disease burden and for various healthcare policies. The incidence of CHD in live births is loosely referred to as prevalence of CHD in many studies, and studies in older children report spot prevalence of CHD: the authors also refer to the disease burden as prevalence of CHD in this article.
Earlier estimates, as summarised by Hoffman reported low frequency of CHD at about 4 to 5 per 1,000 live births [9] . Recent studies, however, suggest an increase in the prevalence of CHD with reported frequency of 12 to 14 per 1,000 live births, or even higher [10] . In the landmark Baltimore-Washington Infant Study (BWIS) conducted in 1980s, prevalence of CHD was 4.8 per 1,000, but it was 9 per 1,000 in study from Atlanta conducted during 1990s [5, 6] . A closer look of the pattern of CHDs indicates that the variation in incidence/prevalence of different studies is largely the result of variation in ascertainment methods and is driven by inclusion of common and generally mild lesions. The potential for variable reporting and ascertainment is particularly great in these lesions. Studies using echocardiography may include cardiac lesions like small muscular ventricular septal defect (VSD) and atrial septal defect (ASD) with little clinical importance and high rate of spontaneous closure and consequently, overestimate the prevalence. This is evident by a steep rise in prevalence of CHD reported by studies in echocardiography era [11] with some of the highest prevalence rates reported by studies using echocardiography for screening [10] . Some of the large epidemiological studies are summarised in Table 1 .
Furthermore, some of the later studies like the Norwegian study which showed an even higher prevalence of 14.6 per 1,000 live births have used fetal echocardiography as the screening tool [7] . The impact of availability of fetal echocardiography on the prevalence of CHD can be variable. It increases the number of patients with CHD due to routine screening but on the other hand, it can underestimate the prevalence due to exclusion of cardiac lesions like small VSD, ASD, patent ductus arteriosus (PDA) or coarctation of aorta. In addition, by promoting elective termination of pregnancy it can lead to reduction in incidence at birth, especially of complex CHDs if measured postnatally [12, 13] . Any assessment of the prevalence of CHD must therefore take into account the age of the patient population and method of ascertainment.
According to a recent systematic review, highest prevalence of CHD is reported from Asia (9.3 per 1,000 live births) while the least is reported from Africa (1.9 per 1,000 live births). Such geographical dissimilarity is mostly due to the differences in ascertainment. Given the uncertainties of estimation, there is no conclusive evidence that the true prevalence of CHD is different across the globe, or that it is changing over time. Some argue that not only reported but also the true CHD prevalence has changed over time. Survival of premature infants has improved over the last century, attributing to an increase in total CHD and especially PDA [9] . Furthermore, because increasing numbers of women are delaying the childbearing, maternal age has increased causing a higher prevalence of congenital abnormalities [14] . In addition, with advances in healthcare worldwide, the patient population with adult CHD is steadily increasing with their offspring at increased risk of having CHD [15] .
There are some data to suggest true geographic variations in the type of CHD. For e.g., studies from Asian countries have reported relatively more right ventricular outflow obstructive lesions compared to left ventricle outflow tract obstructive lesions [11] , and the supracristal type of VSD is much commoner in orientals as compared to the rest of the world [16] . Analysis of such variations might help identifying the etiology of some cardiac lesions.
In contrast to large epidemiological studies from developed countries, studies from India [17] [18] [19] [20] [21] [22] [23] [24] [25] (Table 2) . Unfortunately, all communitybased studies except the study by Chadha et al. [22] have focused on older age groups and not included children below 5 y of age rendering them highly unreliable for the question of prevalence of CHD. Other studies being hospital-based are dependent on patient reporting and have high likelihood of reporting bias. Thus large methodologically sound community based studies are required.
In this issue, Sawant et al. [26] and Bhat et al. [27] provide more data on the 'prevalence and pattern of CHD in India'. The authors need to be congratulated for providing estimation of the burden of CHD in the current era. The prevalence and pattern of CHD reported in these studies is similar to the published literature. [26] . On the other hand, in large study of 36,541 patients, Bhat et al. studied both in-patient deliveries and out patient referrals and therefore, has high potential of reporting bias [27] . However, small number of neonates studied by Sawant et al., and lack of information regarding total number of infants studied by Bhat et al. makes them unlikely to represent the prevalence of CHD in the population [26, 27] .
28.5 % subjects in the study by Sawant et al., had their murmur detected after first wk of life, which could only be detected by regular follow up [26] . In the absence of universal echocardiographic screening, this data attains greater significance and emphasises the need of follow-up visits during infancy to facilitate early detection of CHD. This is further highlighted by the observation made in the study by Bhat et al., where nearly one-third of patients had their diagnosis beyond 6 y of age [27] . In a well-executed follow up of study cohort by Sawant et al., all CHD patients were managed according to the type of cardiac lesion and clinical requirement [26] . Bhat et al., on the other hand reports very small percentage (9.3 %) of CHD patients receiving definitive treatment in a tertiary care hospital [27] . This disparity brings out an important aspect of non-uniform availability of healthcare in the country. In summary, the introduction of echocardiography has increased the reported prevalence of CHD. There is a lack of community-based, methodologically sound, large epidemiologically validated study at birth from India. Moreover, in the current era of rapid economic growth and development, persistent late detection of untreated CHD in India is disturbing and needs attention.
